Literature DB >> 24026565

Quality of life and fecal incontinence after transanal endoscopic microsurgery for benign and malignant rectal lesions.

Elsa B Valsdottir1, Shadi S Yarandi, John H Marks, Gerald J Marks.   

Abstract

BACKGROUND: Transanal endoscopic microsurgery (TEM) is a minimally invasive treatment used to excise a variety of rectal lesions. Potential overstretching of the sphincter's musculature due to dilation of the anal canal to allow placement of a 40-mm-wide scope combined with partial resection of the rectum and subsequent loss of rectal volume creates a concern regarding anorectal function postoperatively. Data regarding patient satisfaction with anorectal function and quality of life after TEM are scant. This report presents data on patient satisfaction gathered during a period of 10 years.
METHODS: A prospectively maintained database of patients undergoing TEM from 1997 to 2007 was queried to identify patients to survey using the Fecal Incontinence Quality of Life Scale questionnaire, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) questionnaire version 3, and a questionnaire designed by the authors to assess satisfaction with quality of life. From a group of 86 patients, 57 (66 %) responded to the questionnaires. Patient satisfaction outcomes were determined by age, preoperative diagnosis, tumor level in the rectum, excision method, and radiation treatment.
RESULTS: Most of the patients (94.7 %) preferred TEM to having a stoma. Age (p = 0.03) and nature of the lesion (p = 0.03) were the only factors that affected coping. Depression was affected only by the presence of malignancy (p = 0.001). Excision method was the only factor that significantly influenced overall lifestyle (p = 0.002). Neither tumor level (p = 0.8) nor radiation therapy (p = 0.9) affected patient satisfaction with lifestyle after TEM. The presence of malignancy (p = 0.004) and full-thickness excision (p = 0.02) were related to more problems with fecal incontinence.
CONCLUSION: Satisfaction with fecal continence generally is high after TEM. Tumor level, size of tumor, and radiation therapy do not affect the level of satisfaction after TEM. Younger age and benign nature of the lesion help patients to cope better with lifestyle changes and reduce depression. Patients with submucosal excision have a significantly higher level of satisfaction.

Entities:  

Mesh:

Year:  2013        PMID: 24026565     DOI: 10.1007/s00464-013-3155-5

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  26 in total

Review 1.  Psychological factors in postoperative adjustment to stoma surgery.

Authors:  C A White; J C Hunt
Journal:  Ann R Coll Surg Engl       Date:  1997-01       Impact factor: 1.891

2.  Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery.

Authors:  E Lezoche; M Guerrieri; A M Paganini; M Baldarelli; A De Sanctis; G Lezoche
Journal:  Br J Surg       Date:  2005-12       Impact factor: 6.939

3.  High-dose preoperative radiation and full-thickness local excision. A new option for patients with select cancers of the rectum.

Authors:  G Marks; M M Mohiuddin; L Masoni; L Pecchioli
Journal:  Dis Colon Rectum       Date:  1990-09       Impact factor: 4.585

4.  Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer.

Authors:  P G Doornebosch; R A E M Tollenaar; M P Gosselink; L P Stassen; C M Dijkhuis; W R Schouten; C J van de Velde; E J R de Graaf
Journal:  Colorectal Dis       Date:  2007-07       Impact factor: 3.788

Review 5.  Incontinence severity and QOL scales for fecal incontinence.

Authors:  Todd H Rockwood
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

6.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

7.  Rectal cancer surgery with sphincter preservation: functional results related to the level of anastomosis. Clinical and instrumental study.

Authors:  Chiara Montesani; Annamaria Pronio; Sergio Santella; Arianna Boschetto; Daniele Aguzzi; Roberto Pirozzi; Alberto D'Amato; Annatita Vestri
Journal:  Hepatogastroenterology       Date:  2004 May-Jun

8.  Outcome of transanal endoscopic microsurgery and adjuvant radiotherapy in patients with T2 rectal cancer.

Authors:  Simon D Duek; Nidal Issa; Dan D Hershko; Michael M Krausz
Journal:  Dis Colon Rectum       Date:  2008-01-31       Impact factor: 4.585

9.  Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex.

Authors:  Robert S Krouse; Lisa J Herrinton; Marcia Grant; Christopher S Wendel; Sylvan B Green; M Jane Mohler; Carol M Baldwin; Carmit K McMullen; Susan M Rawl; Eric Matayoshi; Stephen Joel Coons; Mark C Hornbrook
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Impact of transanal endoscopic microsurgery on functional outcome and quality of life.

Authors:  P G Doornebosch; M P Gosselink; P A Neijenhuis; W R Schouten; R A E M Tollenaar; E J R de Graaf
Journal:  Int J Colorectal Dis       Date:  2008-04-01       Impact factor: 2.571

View more
  9 in total

1.  Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms.

Authors:  G Rizzo; D P Pafundi; F Sionne; L D'Agostino; G Pietricola; M A Gambacorta; V Valentini; C Coco
Journal:  Tech Coloproctol       Date:  2021-01-18       Impact factor: 3.781

2.  Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision.

Authors:  Giancarlo D'Ambrosio; Alessandro M Paganini; Andrea Balla; Silvia Quaresima; Pietro Ursi; Paolo Bruzzone; Andrea Picchetto; Fabrizio I Mattei; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2015-06-05       Impact factor: 4.584

Review 3.  The evolution of cancer surgery and future perspectives.

Authors:  Lynda Wyld; Riccardo A Audisio; Graeme J Poston
Journal:  Nat Rev Clin Oncol       Date:  2014-11-11       Impact factor: 66.675

4.  [Oncological result of T1N0M0 rectal adenocarcinoma : comparison of local and radical procedures].

Authors:  P Mroczkowski; C J Bruns
Journal:  Chirurg       Date:  2015-03       Impact factor: 0.955

5.  Quality of life in patients with loco-regional rectal cancer after ELRR by TEM versus VLS TME after nChRT: long-term results.

Authors:  Giancarlo D'Ambrosio; Andrea Picchetto; Salvatore Campo; Rossella Palma; Cristina Panetta; Francesca De Laurentis; Stefania La Rocca; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2018-11-12       Impact factor: 4.584

6.  Quality of Life and Functional Outcome After Transanal Abdominal Transanal Proctectomy for Low Rectal Cancer.

Authors:  John H Marks; Jean F Salem; Elsa B Valsdottir; Shadi S Yarandi; Gerald J Marks
Journal:  Dis Colon Rectum       Date:  2017-03       Impact factor: 4.585

7.  Prognosis of Patients Over 60 Years Old With Early Rectal Cancer Undergoing Transanal Endoscopic Microsurgery - A Single-Center Experience.

Authors:  Mingqing Zhang; Yongdan Zhang; Haoren Jing; Lizhong Zhao; Mingyue Xu; Hui Xu; Siwei Zhu; Xipeng Zhang
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

8.  Transanal Endoscopic Microsurgery (TEMS) for Rectal Cancer: Patient Decision-making, Postoperative Experience and Quality of Life.

Authors:  Alexandra Koreli; George Briassoulis; Michail Sideris; Anastas Philalithis; Savvas Papagrigoriadis
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

9.  Comparison of transanal endoscopic microsurgery with or without neoadjuvant therapy and standard total mesorectal excision in the treatment of clinical T2 low rectal cancer: a meta-analysis.

Authors:  Zheng-Shui Xu; Hua Cheng; Yuhong Xiao; Jun Luo; Wei Xu; Jia-Qing Cao; Fei Cheng; Wen-Ji Xu; Jia-Qi Ying
Journal:  Oncotarget       Date:  2017-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.